CLEVELAND, Ohio — Lubrizol Life Science Health (LLS Health) has announced that it is expanding its product development partnership with B. Braun, an international medical technology and pharmaceutical company.
The strategic partnership will see the two companies collaborate to develop the next generation of medical devices, which will feature a patented Lubrizol polymer technology designed to increase patient safety and prolong the functional life of medical devices derived from it.
“This opportunity to work with a trusted partner will help Lubrizol deliver real-world impact as part of our mission to help the world Live Better,” Darren Tuel, Senior Director of Strategic Marketing, LLS Health said. “Leveraging our extensive capabilities in medical device design and manufacturing with our longstanding expertise in biocompatible polymer science, we hope this product development partnership will deliver breakthrough solutions and effective technologies aimed at improving patient safety and clinical outcomes.”
“Safe and efficient new products are not only based on intelligent design, but also on innovative materials,” Dr. Meinrad Lugan, B. Braun board member added. “With Lubrizol Life Science we found a strategic partner with unmatched experience and know-how who will support us to develop the next generation of medical devices optimizing treatment efficiency and effectiveness as well as patient safety.”
The partnership of Lubrizol and B. Braun reflects Lubrizol Corporation’s ‘Live Better’ mission, which pledges to improve at least 2 billion lives by 2028 through utilizing its formulation expertise, testing capabilities, market insights and global scale.
